We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Gold Supplier
Infectious Diseases Controls
Multichem ID-SeroNeg
Urine Analyzer
Hepatitis/HBcAb CLIA Test
EML4-ALK/KIF5B-ALK Fusion Gene Detection Test
QFusion EML4-ALK and KIF5B-ALK Fusion Gene Detection Test
Visit expo >

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Molecular Diagnostics

Image: Liquid biopsies could predict survival odds for patients with metastatic cancer (Photo courtesy of Michigan Medicine)

Blood Tests Could Predict Survival Odds for Patients with Metastatic Cancer

A new study has found that measuring the amount of DNA that has been shed by a tumor compared to the body’s typical amount of DNA, defined as the tumor fraction, may be a new tool to predict survival and guide treatment discussions for patients whose cancer has spread from the breast, prostate, lung or colon. More...
30 Nov 2022
Image: PepSeq is a fully in vitro platform for highly multiplexed serology using customizable DNA-barcoded peptide libraries (Photo courtesy of Northern Arizona University)

New Serological Test Could Search for Viral Triggers of Diseases

A new serological test can not only help humanity prepare for and respond to the next pandemic, but it also can be pivotal in the search for viral triggers of diseases like diabetes and celiac disease.  More...
30 Nov 2022
Image: Juno HAZEL is an innovative solution to increase accessibility and affordability of NIPS (Photo courtesy of Juno Diagnostics)

Blood-Based NIPS Test Improves Access to Genetic Testing

Juno Diagnostics (San Diego, CA, USA) has launched Juno Hazel, a non-invasive prenatal screening (NIPS) solution enabled from finger-prick amounts of blood. More...
29 Nov 2022
Image: Corticobasal degeneration (CBD): diagram of the basal ganglia (in red) and related structures (in blue) within the brain. Basal ganglia along with cerebral cortex are involved in this condition (Photo courtesy of Wikimedia Commons)

Two Tau Variants Distinguish Corticobasal Degeneration from Other Tauopathies

Biomarkers have been found that identify, with up to 89% accuracy, individuals with the primary tauopathy, corticobasal degeneration. More...
28 Nov 2022
Image: A cheap blood test could improve diagnosis of myocarditis (Photo courtesy of Queen Mary University of London)

First-Ever Blood Test Could Detect Deadly Heart Inflammation Within Hours

Myocarditis, or inflammation of the heart muscle, is a difficult condition to diagnose. Now, the discovery of a molecular signal in the blood could pave the way for the first blood test to be used for diagnosing myocarditis within as little as a year. More...
25 Nov 2022
Image: UriFind is a urine-based, non-invasive molecular test for detection of bladder cancer (Photo courtesy of Pexels)

Urine-Based, Non-Invasive Molecular Test Accurately Detects Bladder Cancer

A new study aims to evaluate the performance of a non-invasive, quantitative real-time PCR (qPCR) assay designed to detect two DNA methylation biomarkers in urine specimens from patients suspected of having bladder cancer. More...
25 Nov 2022
Image: A micrograph showing cells with abnormal p53 expression (brown) in a brain tumor (Photo courtesy of Wikimedia Commons)

Altered Ratios of p53 Isoforms Predict Response of Breast Tumors to Chemotherapy

Alterations in the distribution of p53 isoforms are predictive of the likelihood that a breast tumor will respond to treatment with the chemotherapeutic drug doxorubicin. More...
24 Nov 2022

Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2022 Globetech Media. All rights reserved.